Navigation Links
HUYA Bioscience International and Zhongshan National Health Technology Park Establish Alliance
Date:7/21/2011

SAN DIEGO, July 21, 2011 /PRNewswire/ -- HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovations, today announced a strategic partnership with the Zhongshan National Health Technology Park. The alliance will unite the strength and resources of both parties to accelerate the development of China's pharmaceutical discoveries.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. The company is committed to facilitating and promoting the global development and commercialization of novel pharmaceutical products originating in China. HUYA has established a series of collaborations with leading universities and research institutions throughout China and has pioneered in-licensing clinical stage compounds from the country, utilizing its expertise to advance these compounds for global markets.

Zhongshan National Health Technology Park, jointly established by the Ministry of Science and Technology, Guangdong Provincial Government and Zhongshan Municipal Government, is the first nationally designated health industrial park in China that has been built in compliance with the international standards of GLP, GMP and GCP, which qualifies the development, clinical experiments and production of new medicines.  Situated at the Torch Hi-tech Industrial Development Zone in Zhongshan, Guangdong, the park has attracted numerous national and international enterprises and has formed co-operational relationships with renowned universities worldwide.

Under the agreement, Zhongshan National Health Technology Park and HUYA will collaborate to promote new drug development. HUYA may attend project promotion events and actively participate in the annual Health and Development Zhongshan Forums at the park, or organize HUYA's partners to participate in the events. HUYA may also recommend its global pharmaceutical partners to collaborate with the park.

HUYA will have the first opportunity to provide assistance in evaluating R&D projects conducted by pharmaceutical enterprises residing in the park.  HUYA will be able to internationalize select programs through HUYA's innovative co-development model and the company's worldwide pharmaceutical partners, thereby introducing qualified projects from companies in the park into global markets.

"This exciting partnership between HUYA and Zhongshan National Health Technology Park will support innovation and growth of China's pharmaceutical industry," said Clement Gingras, HUYA's CTO and COO, China. "HUYA and Zhongshan National Health Technology Park share the goal of improving the health and lives of people by providing innovative pharmaceutical products."

Conghong Yu, Director of Zhongshan Health Technology Park, commented, "With HUYA's expertise in developing innovative products in accordance with international standards, this alliance will certainly aid the park's endeavor to become a nationally and internationally known health technology industrial base."

ABOUT HUYA BIOSCIENCE INTERNATIONAL

HUYA is the leader in global pharmaceutical co-development with Chinese partners. With seven offices strategically located in China, the most comprehensive Chinese compound portfolio, and a rapidly growing number of exclusive agreements with premier Chinese research and development organizations, HUYA is uniquely positioned to identify and license novel Chinese compounds. HUYA offers Western pharmaceutical companies efficient access to innovative therapeutic opportunities and helps to reduce deal-making complexity in China. The company has become a champion of guiding China's biomedical innovations to the worldwide marketplace. HUYA has joint headquarter offices in San Diego, CA, USA and Shanghai, China. Additional information about the company is available at www.huyabio.com.

ABOUT ZHONGSHAN NATIONAL HEALTH TECHNOLOGY PARK

Zhongshan National Health Technology Park is situated in the Torch Hi-tech Industrial Development Zone in Zhongshan, Guangdong province and covers a land area of 13.5 square km. It is the first established national-level health technology industrial base in China. The park has gathered a large number of national and worldwide companies which are engaged in the industrial fields of Chinese herbal and western synthetic medicines, healthcare products, biological engineering, health foods, medical apparatus, cosmetics and pharmaceutical packaging materials. Its total industrial output value in 2010 amounted to more than US $2.7 billion.  Zhongshan National Health Technology Park has set up its future development strategy, it will continue to grow and implement its Greater Health industrial concept to develop the business in the direction of internationalization and standardization in accordance to international practice. For more information, please visit www.zstorch.gov.cn.

CONTACT

USA:
Yung-Chih Wang, Ph.D., MBA
Vice President, Corporate Development, China
HUYA Bioscience International
+1.858.798.8800
ywang@huyabio.com

China:
Qing (Vicky) Xia, MS, MBA
Senior Business Development Manager
HUYA Bioscience International
+86.21.51323312
vxia@huyabio.com


'/>"/>
SOURCE HUYA Bioscience International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Magellan Biosciences Sells TREK Microbiology Business to Thermo Fisher Scientific
2. Coronado Biosciences Files to Become a Public Reporting Company
3. SARcode Bioscience Completes $44 Million Series B Financing
4. HUYA BIOSCIENCE INTERNATIONAL ENGAGES IN PARTNERSHIP WITH LIAONING (BENXI) BIO-PHARMACEUTICAL INDUSTRY BASE
5. Coronado Biosciences Closes $25.8M in Series C Financing
6. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
7. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
8. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
9. BIOSCIENCE EAST, the Life Sciences Industry Map, Highlighting Global Leaders in Healthcare Innovation, Kicks Off 5th Edition
10. Generex Announces Intention to Dividend a Portion of Anticipated Amarantus BioSciences Shares to Its Shareholders upon a Reverse Stock Split
11. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
Breaking Medicine News(10 mins):